NCT05689710

The Effects of Inositol on Glucose Metabolism in Patients With Metabolic Syndrome at Risk of Cardiac Fibrosis

The Action of Inositols and Alpha-lactalbumin on Glucose Metabolism, Arterial Stiffness and Vascular Damage in Patients With Metabolic Syndrome at Risk of Cardiac Fibrosis

• Status: Suspended
• Phase: N/A
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: Lo.Li.Pharma s.r.l · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The study aims to evaluate the effects of an oral supplementation based on inositols and alpha-lactalbumin on principals metabolic parameters in patients with metabolic syndrome at risk of cardiac fibrosis

Conditions

• Metabolic Syndrome
• Cardiac Fibrosis

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Inositol and alpha-lactalbumin	The administration of an oral formulation based on inositol and alpha-lactalbumin (two sachets/day for 180 days)

Timeline

• Start date: 2022-12-23
• Primary completion: 2026-01-01
• Completion: 2026-01-01
• First posted: 2023-01-19
• Last updated: 2025-12-30

Locations

1 site across 1 country: Italy